EUVIMEDEUVIMED entdecken
Crossref

Kinetics of Molecular Response to Imatinib in Patients With Chronic Myeloid Leukemia May Predict Persistent Polymerase Chain Reaction Negativity After Imatinib Discontinuation

Carmen Fava, Stefano Ulisciani, Emilia Giugliano, Vanessa Brunetto, Enrico Gottardi, Lorena Giaretto, Giuseppe Saglio, Giovanna Rege-Cambrin

Clinical Lymphoma and Myeloma · 2009-12 · 9 (6) · E42

DOI: 10.3816/clm.2009.n.103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lymphoma and Myeloma, 2009-12. Verfasst von Carmen Fava und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Fava, C., Ulisciani, S., Giugliano, E., Brunetto, V., Gottardi, E., Giaretto, L., Saglio, G., & Rege-Cambrin, G. (2009). Kinetics of Molecular Response to Imatinib in Patients With Chronic Myeloid Leukemia May Predict Persistent Polymerase Chain Reaction Negativity After Imatinib Discontinuation. Clinical Lymphoma and Myeloma, 9(6), E42. https://doi.org/10.3816/clm.2009.n.103

Vancouver

Fava C, Ulisciani S, Giugliano E, Brunetto V, Gottardi E, Giaretto L, et al. Kinetics of Molecular Response to Imatinib in Patients With Chronic Myeloid Leukemia May Predict Persistent Polymerase Chain Reaction Negativity After Imatinib Discontinuation. Clinical Lymphoma and Myeloma. 2009;9(6):E42. doi:10.3816/clm.2009.n.103

BibTeX
@article{Fava2009,
  author = {Fava, Carmen and Ulisciani, Stefano and Giugliano, Emilia and Brunetto, Vanessa and Gottardi, Enrico and Giaretto, Lorena and Saglio, Giuseppe and Rege-Cambrin, Giovanna},
  title = {Kinetics of Molecular Response to Imatinib in Patients With Chronic Myeloid Leukemia May Predict Persistent Polymerase Chain Reaction Negativity After Imatinib Discontinuation},
  journal = {Clinical Lymphoma and Myeloma},
  year = {2009},
  volume = {9},
  number = {6},
  pages = {E42},
  doi = {10.3816/clm.2009.n.103}
}
Kostenlos starten →